Pericapsular Nerve Group Block (PENG Block)

3

Review clinical trials related to Pericapsular Nerve Group Block (PENG Block). Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

PENG+LFCN Block vs QIPB for Total Hip Arthroplasty

This randomized clinical trial aims to evaluate and compare the analgesic efficacy and functional outcomes of the quadro-iliac plane block (QIPB) and the pericapsular nerve group (PENG) block combined with lateral femoral cutaneous nerve(LFCN) block in patients undergoing total hip arthroplasty. The primary outcome is the Numeric Rating Scale (NRS) within the first 48 hours after surgery. Secondary outcomes include postoperative total opioid consumption, ıncidence of quadriceps motor block, time to first ambulation, block performance time, falls, length of hospital stay, block- related complications(hematoma,local anesthetic systemic complications, vascular puncture, and infection), patient satisfaction assessed using a Likert scale, and incidence of postoperative nausea and vomiting.

Participants needed: 60
Trial details
Age: 18-80Biological sex: AllType: InterventionalSponsor: Antalya City HospitalUpdated: Jun 25, 2026
Eligibility criteria

Age between 18 and 80 years [+5]

Refusal to participate [+14]

Status: Not yet recruiting

Ultrasound-Guided PENG Block for Chronic Shoulder Pain

The purpose of this prospective, observational study is to evaluate the clinical and functional outcomes of ultrasound-guided Pericapsular Nerve Group (PENG) block in patients suffering from chronic shoulder pain. Chronic shoulder pain is a highly prevalent musculoskeletal problem that significantly restricts daily activities and diminishes the patient's quality of life. While conservative treatments and various interventional injections are widely used, long-term efficacy can be limited, and systemic side effects may occur. The shoulder PENG block is a novel regional analgesia technique that specifically targets the articular (sensory) branches of the nerves innervating the shoulder joint capsule without affecting the motor branches. In this single-center study, a total of 45 eligible adult patients with chronic shoulder pain who did not respond to conservative medical treatments will receive an ultrasound-guided PENG block as part of their routine clinical care. The procedure will be performed under sterile conditions using a combination of local anesthetic (lidocaine) and dexamethasone. Patient pain levels will be assessed using the Numerical Rating Scale (NRS), shoulder disability and functional status will be measured using the Shoulder Pain and Disability Index (SPADI), and overall patient satisfaction will be evaluated using the Global Perceived Effect (GPE) score. All parameters will be documented at baseline (before the procedure) and at follow-up visits on the 1st week, 4th week (1 month), and 3rd month post-procedure. The investigators aim to determine the efficacy, duration of effect, and safety profile of this intervention.

Participants needed: 45
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Ankara City Hospital BilkentUpdated: May 26, 2026Locations: 1
Eligibility criteria

Age 18 years or older. [+4]

Patients currently using anticoagulants or diagnosed with coagulation disorders... [+6]

Status: Not yet recruiting

COmparison of PENG Block and SIFICB in Hip Fracture Surgeries

The aim of this study is to compare the effectiveness of the PENG block and SIFIB in facilitating the positioning for neuroaxial anesthesia and their impact on the quality of postoperative analgesia.

Participants needed: 150
Trial details
Age: 40-80Biological sex: AllType: InterventionalSponsor: Adiyaman University Research HospitalUpdated: Mar 17, 2025
Eligibility criteria

Hip fractures [+1]

Contraindicated to spinal anesthesia [+3]